The Biomics team uses functional genomics and phenomics approaches (RNAi-based high content and throughput screening) on human cells grown in 3D (organoid, spheroids, organs on chip) to characterize new biomarkers and therapeutic targets in oncology.
The team develops a range of proteomics approaches as part of a broad range of biologically relevant projects. The team has considerable expertise in the fields of protein quantification by mass spectrometry and proteomics analysis of complex biological systems.
The team develops genetics and chemogenomics approaches for the identification and study of proteins and small chemicals functions in cell signalling. The team pursues both a research project which aims in the characterization of novel mechanisms of regulation of innate immune and inflammatory signals, and facilities and R&D activities at the Center for the screening for BioActive Molecules (CMBA).
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.